| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Physiology and Pharmacology (A.L.M., T.J., T.L.P.), Perinatal Center, S-405 30 Göteborg, Sweden; Department of Paediatrics (I.J.W.), Atlantic Research Centre, Dalhousie University, Halifax, Canada; and Department of Obstetrics and Gynecology (M.W.), Göteborg University, S-41685 Göteborg, Sweden
Address all correspondence and requests for reprints to: Anne Liese Magnusson, Perinatal Center, Department of Physiology and Pharmacology, Göteborg University, Box 432, S-405 30 Göteborg, Sweden. E-mail: anneliese.magnusson{at}fysiologi.gu.se.
Triglyceride (TG) hydrolases in the placental microvillous plasma membrane (MVM) release fatty acids from circulating lipoproteins and represent the critical initial step in transplacental fatty acid transfer. We investigated the activity of two TG hydrolases in MVM isolated from placentas of appropriately grown for gestational age pregnancies and pregnancies complicated by intrauterine growth restriction (IUGR), insulin-dependent diabetes mellitus (IDDM) or gestational diabetes mellitus (GDM). In addition, we measured protein expression of lipoprotein lipase (LPL) in MVM and two fatty acid binding proteins (L- and C-FABP) in placental homogenates. The TG hydrolase activities were assessed by measuring hydrolysis of 3H-trioleic acid incorporated into intralipid micelles after incubation with MVM. The placenta-specific TG hydrolase activity (optimum at pH 6) did not differ in the patient groups studied. MVM LPL activity (optimum at pH 8) was reduced by 47% in preterm IUGR (n = 8, P < 0.05), compared with gestational age-matched controls. The LPL activity in placentas of IDDM pregnancies was increased by 39% (n = 8, P < 0.05), compared with controls. No significant differences were observed in cases of GDM. We found no alteration in protein expression of LPL or C-FABP. The expression of L-FABP was increased by 112% (n = 8, P < 0.05) in IDDM and 64% (n = 8, P < 0.05) in GDM. These results indicate that alterations in MVM LPL activity and expression of L-FABP may contribute to the altered lipid deposition and metabolism in IUGR and diabetic pregnancies.
This article has been cited by other articles:
 |
|
 |
|
  P. Cunningham and L. McDermott Long Chain PUFA Transport in Human Term Placenta J. Nutr., April 1, 2009; 139(4): 636 - 639. [Full Text] [PDF]
|
|
|
|
 |
|
 S. M. Nelson, D. J. Freeman, N. Sattar, F. D. Johnstone, and R. S. Lindsay IGF-1 and Leptin Associate With Fetal HDL Cholesterol at Birth: Examination in Offspring of Mothers With Type 1 Diabetes Diabetes, November 1, 2007; 56(11): 2705 - 2709. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. L. Magnusson-Olsson, S. Lager, B. Jacobsson, T. Jansson, and T. L. Powell Effect of maternal triglycerides and free fatty acids on placental LPL in cultured primary trophoblast cells and in a case of maternal LPL deficiency Am J Physiol Endocrinol Metab, July 1, 2007; 293(1): E24 - E30. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Ericsson, K. Saljo, E. Sjostrand, N. Jansson, P. D. Prasad, T. L. Powell, and T. Jansson Brief hyperglycaemia in the early pregnant rat increases fetal weight at term by stimulating placental growth and affecting placental nutrient transport J. Physiol., June 15, 2007; 581(3): 1323 - 1332. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Gauster, U. Hiden, A. Blaschitz, S. Frank, U. Lang, G. Alvino, I. Cetin, G. Desoye, and C. Wadsack Dysregulation of Placental Endothelial Lipase and Lipoprotein Lipase in Intrauterine Growth-Restricted Pregnancies J. Clin. Endocrinol. Metab., June 1, 2007; 92(6): 2256 - 2263. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. L. Magnusson-Olsson, B. Hamark, A. Ericsson, M. Wennergren, T. Jansson, and T. L. Powell Gestational and hormonal regulation of human placental lipoprotein lipase J. Lipid Res., November 1, 2006; 47(11): 2551 - 2561. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. L. S. Lindegaard, P. Damm, E. R. Mathiesen, and L. B. Nielsen Placental triglyceride accumulation in maternal type 1 diabetes is associated with increased lipase gene expression J. Lipid Res., November 1, 2006; 47(11): 2581 - 2588. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Khare, A. H. Taylor, J. C. Konje, and S. C. Bell {Delta}9-Tetrahydrocannabinol inhibits cytotrophoblast cell proliferation and modulates gene transcription Mol. Hum. Reprod., May 1, 2006; 12(5): 321 - 333. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. E. Murphy, R. Smith, W. B. Giles, and V. L. Clifton Endocrine Regulation of Human Fetal Growth: The Role of the Mother, Placenta, and Fetus Endocr. Rev., April 1, 2006; 27(2): 141 - 169. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Min, C. Lowy, K. Ghebremeskel, B. Thomas, B. Offley-Shore, and M. Crawford Unfavorable effect of type 1 and type 2 diabetes on maternal and fetal essential fatty acid status: a potential marker of fetal insulin resistance Am. J. Clinical Nutrition, December 1, 2005; 82(6): 1162 - 1168. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. L. S. Lindegaard, G. Olivecrona, C. Christoffersen, D. Kratky, J. Hannibal, B. L. Petersen, R. Zechner, P. Damm, and L. B. Nielsen Endothelial and lipoprotein lipases in human and mouse placenta J. Lipid Res., November 1, 2005; 46(11): 2339 - 2346. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |
